Table 1.
Demographics and clinical characteristics of Parkinson's disease patients and controls.
| PD patients (n = 98) | Controls (n = 26) | p value | |
|---|---|---|---|
| Gender | 28F 70M | 10F 16M | 0.33 |
| Age (years) | 64.0 ± 0.82 (42–81) | 62.0 ± 1.40 (49–76) | 0.24 |
| MDS-UPDRS III | 29.0 ± 1.18 (7–65) | ||
| Disease duration (months) | 58.0 ± 4.8 (2–249) | ||
| Hoehn and Yahr stage | I:21 II:63 III:14 | ||
| MoCA (n = 77) | 26.0 ± 0.3 (17–30) |
Data shown as mean ± SEM (range). PD: Parkinson’s disease, MDS UPDRS III: movement disorder society unified Parkinson’s disease rating scale part III, MoCA: montreal cognitive assessment.